VS
Vivek Srinivasan
About Vivek Srinivasan
Data last updated:
Vivek Srinivasan is a Cfo at Neuberg Diagnostics Private Limited (since 2024), Director at Gemini Scans Private Limited (since 2025) and Additional Director at Neuberg Center For Genomic Medicine Private Limited (since 2026), and holds 1 more current directorship. The companies operate in Healthcare and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹896 Cr; the largest is Neuberg Diagnostics Private Limited at ₹853 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 12 Dec 2024 | 2017 | ₹853 Cr (FY 2025) | Active | |
| Director | 14 Jul 2025 | 2006 | ₹38.61 Cr (FY 2025) | Active | |
| Additional Director | 16 Jan 2026 | 2021 | ₹4.52 Cr (FY 2025) | Active | |
| Designated Partner | 10 Sep 2021 | 2021 | Under Process Of Striking Off |
Board colleagues of Vivek Srinivasan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Srinivasan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Srinivasan
Vivek Srinivasan currently holds 4 directorships: Neuberg Diagnostics Private Limited (Cfo, since 12 Dec 2024, revenue ₹853 Cr (FY 2025)); Gemini Scans Private Limited (Director, since 14 Jul 2025, revenue ₹38.61 Cr (FY 2025)); Neuberg Center For Genomic Medicine Private Limited (Additional Director, since 16 Jan 2026, revenue ₹4.52 Cr (FY 2025)); Innate Alliance Llp (Designated Partner, since 10 Sep 2021).
Vivek Srinivasan was first appointed on 10 Sep 2021 as Designated Partner at Innate Alliance Llp. The most recent appointment on record is 16 Jan 2026 at Neuberg Center For Genomic Medicine Private Limited.
The 3 current companies of Vivek Srinivasan that report revenue have a combined latest revenue of ₹896 Cr: Neuberg Diagnostics Private Limited ₹853 Cr (FY 2025); Gemini Scans Private Limited ₹38.61 Cr (FY 2025); Neuberg Center For Genomic Medicine Private Limited ₹4.52 Cr (FY 2025).
The current boards of Vivek Srinivasan's companies include Athmanathan Ganesan (Neuberg Diagnostics Private Limited), Gomathy Babu Sadacharam Kulandaivelu (Neuberg Diagnostics Private Limited), Rahul Dilip Shah (Neuberg Diagnostics Private Limited), Roshini Selvakumar (Neuberg Diagnostics Private Limited), Sandip Chandrakant Shah (Neuberg Diagnostics Private Limited), Sujay Ramaprasad (Neuberg Diagnostics Private Limited), among others.